Company
Cerevel Therapeutics Holdings, Inc. (0001805387)
Standardized SEC financial data for Cerevel Therapeutics Holdings, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001805387 · Pharmaceutical Preparations.
Return on equity
-64.2%
ROIC
-55.5%
Free cash flow
-$346.1M
Debt / equity
0.56×
Current ratio
10.92×
EPS (diluted)
$-2.67
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 |
| R&D expense | $50.3M | $103.3M |
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $95.4M | $83.7M | $387.8M | $197.2M | $138.4M | $418.4M |
| Total current assets |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Operating cash flow | -$70.7M | -$117.8M | -$178.5M | -$293.2M | -$342.3M |
| Capital expenditures | $1.1M | $18.9M |
Get 0001805387 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001805387/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001805387/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"